summarizes annual rates of hemorrhage from intramedullary CMs. Aside from the observed cohorts in the studies by Cohen-Gadol et al. 10 and Kharkar et al.,
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rates were calculated retrospectively, assuming lesion presence since birth. Annual hemorrhage rates varied from 0 to 4.5%. Over 2571 patient-years for 92 patients in these 6 studies, 63 bleeds occurred, yielding an overall annual hemorrhage rate of 2.5%.
Imaging Characteristics and Differential Diagnosis
The deposition of hemosiderin resulting in a hypointense rim around a mixed signal intensity leads to the pathognomonic appearance of CMs on T2-weighted MR imaging.
14, 45 Cavernous malformations must remain in the differential diagnosis of intradural intramedullary lesions. Infrequently, they may take a more homogeneous hyper-or hypointense appearance. 45 In 24 (34%) of 70 patients (range 0-94% per series) in 6 series, venous malformations were observed. 3, 11, 38, 39, 48, 50 Calcification is seen less frequently with these lesions as compared with their intracranial counterparts (2 of 15 lesions across the series of Cosgrove et al. 11 and Ghogawala and Ogilvy 17 ). Distin- guishing CMs from multiple sclerosis on MR imaging can be difficult because inactive lesions may not enhance and can demonstrate mixed or hyperintense signal intensity. Clinical histories of progressive or recurrent episodes of the neurological decline seen with CMs also mimic multiple sclerosis; however, a distinguishing feature for these lesions in contrast to multiple sclerosis is a symptomatology that is referable to only 1 location of the neuraxis. In addition, demyelinating lesions will more consistently respond to steroids and tend to have more rapid changes in appearance on serial imaging. The broader differential includes spinal ependymomas, astrocytomas, metastatic disease, hemangioblastomas, spinal AVMs, and transverse myelitis. A lack of enhancement can help distinguish CMs from most of these lesions, and cranial MR imaging demonstrating additional CMs can also help elucidate the diagnosis. Angiography will facilitate the diagnosis of a spinal AVM or hemangioblastoma.
Illustrative Case
History and Examination. This 37-year-old healthy man with a family history of CMs presented after an episode of left upper-extremity numbness that left him with residual finger numbness and dysesthesias. Physical examination was remarkable for right biceps muscle weakness and diminished sensation to light touch in his entire left upper extremity distally. Magnetic resonance imaging demonstrated a nonenhancing exophytic lesion at C4-5 with heterogeneous signal intensity, supporting the diagnosis of a spinal intramedullary CM (Fig. 1) . As a healthy young patient with a symptomatic exophytic lesion, the patient was deemed to be an ideal surgical candidate.
Operation. In the operating room, laminectomies from C-4 through C-6 were performed. After opening the dura mater, the exophytic malformation was clearly seen, spreading the posterior columns laterally. It was entered and circumferentially dissected away from the cord, leaving the hemosiderin margin as a guide for the cleavage plane of the lesion. Careful inspection of the cavity after lesion removal revealed no residual malformation. No changes in somatosensory or motor evoked potentials were seen during the case.
Postoperative Course. Postoperatively, transient weakness developed on right wrist dorsiflexion, as did a mild lower-extremity proprioceptive deficit and a worsening of the patient's right upper-extremity sensory deficit. One month after surgery, his motor examination was entirely normal, his dysesthesias had improved, and he was left with only residual finger numbness that had been present at his preoperative examination. Cervical spine MR imaging at 6 months postsurgery demonstrated no residual lesion (Fig. 2) .
Results
Across 24 series with 208 patients, 190 CMs (91%) were totally resected ( Table 4) . Four of 18 residual lesions rebled on follow-up, and 1 patient suffered further neurological decline without a repeat hemorrhage. Transient early postoperative morbidity was reported in 15 series, with rates ranging from 0-100% and a mean of 36% (62 of 171 patients). At the long-term follow-up mentioned in 22 series, 143 patients were improved (61%), 62 (27%) were unchanged, and 28 (12%) were worse, as compared with their preoperative status. These overall results are summarized in Table 5 .
Discussion
The entity of spinal intramedullary CMs was first reported in 1903 in an autopsy study of a 35-year-old woman with a lesion at L-1 that had bled. 21 In 1912 the first successful excision of an intramedullary CM was performed. 40 Resection was complete and the patient's condition improved postoperatively. In the ensuing decades, additional small surgical series and autopsy reports accumulated 2,4,18.24.33,41,43,46,51 until Cosgrove et al. 11 presented the first surgical series of 5 patients in 1988. At that time, most patients still underwent only partial resection or biopsy, and the epidemiology of these lesions was poorly understood.
Natural History and Clinical Presentation
Our findings were mostly consistent with conclusions from prior studies with regard to patient age at presentation, distribution of lesion location, annual hemorrhage rate, and modes of clinical presentation (Table 2) . 6, 52 Early observations of a female preponderance (female/male ratios ranging from 1.5 to 2.2) 6, 52 have been refuted in more recent series 25, 26, 28 with a balance to a more even distribution without a clear sex predilection. Twenty-seven percent of patients had an associated intracranial CM, with approximately 45% of these patients having a family history of CMs. This phenomenon was carefully analyzed in 2 series. Cohen-Gadol et al. 10 obtained cerebral MR images in 33 of 67 cases of spinal intramedullary CMs at their institution, finding 14 with associated cranial and spinal lesions. The mean age in this patient group was 40 years, 12 of the patients were Caucasian, and 8 of the patients had a family history of CMs. Vishteh et al. 49 found that 8 (47%) of 17 patients with spinal intramedullary CMs had at least 1 intracranial lesion as well. The mean age in this patient group was 36 years (as compared with 47 years for those without cranial CMs), with 4 patients (50%) having a family history of CMs. The greater rates of associated cerebral CMs documented in these studies is likely due to selection bias, as only selected patients underwent additional cranial imaging. Nevertheless, these observations encourage imaging of the entire neuraxis when a spinal CM is found-not only in the interest of diagnosing intracranial lesions, but also to facilitate narrowing of the differential diagnosis for spinal lesions that may not have a convincing or characteristic appearance of a CM and avoiding potentially unnecessary angiography.
The clinical presentation of spinal intramedullary CMs can be confused with demyelinating disease, transverse myelitis, intramedullary neoplasms, and spinal AVMs. In their review of 107 patients with 108 lesions, Zevgaridis et al. 52 found that 30% of patients had a stepwise deterioration, 41% a progressive deterioration, and 26% an acute presentation. These rates are similar to our rates of 16%, 54%, and 30%, respectively. As mentioned, progressive decline is likely due to subtle changes in the lesion such as hyalinization/wall thickening, gliosis, microcirculatory changes, partial thrombosis, or microhemorrhage. 34, 42 Acute neurological decline or recurrent episodes of acute decline with varying degrees of recovery are likely due to frank hemorrhage from the lesion. Our review of natural history studies revealed an overall 2.5% annual hemorrhage rate (range 0-4.5%), 3, 10, 25, 36, 38 similar to brainstem cavernomas. 5, 8, 15, 20, 27 Prior reviews of primarily case reports and small case series revealed retrospective annual hemorrhage rates of 1.4-1.6%. 6, 52 Of note, these hemorrhage rates assuming lesion presence since birth are probably underestimates given the potential for de novo CM development.
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Surgical Selection and Technique
Symptoms associated with intramedullary CMs and lesion location will often dictate the course of management. Figure 3 provides a management algorithm for these lesions. Asymptomatic lesions that do not abut a pial surface should be observed. Given that even our 2.5% annual hemorrhage rate is likely an underestimate, as it assumes lesion presence since birth, asymptomatic lesions that are exophytic should be excised to avoid potential future deterioration. Symptomatic lesions that are exophytic should be excised. Symptomatic lesions that are intrinsic should be observed if the findings are minor, transient, or improving. If the patient has recurrent or progressive deficits, these lesions should also be excised using methods such as ultrasonography for intraoperative guidance. The surgeon should be aware that preoperative MR imaging is imperfect in defining whether a lesion is superficial or deep. Vishteh et al. 48 reported a 17.6% false-positive rate for CMs that appeared to abut a pial surface on MR imaging but were actu- ally found to be intrinsic intraoperatively. Weinzierl et al. 50 found that T1-weighted imaging correctly demonstrated 6 of 7 lesions as deep, while T2-weighted imaging correctly showed only 3 of 7 lesions as deep. These findings, likely due to a blooming artifact from the ferromagnetic properties of iron, serve as valuable cautionary observations.
The general approach to these lesions involves a laminectomy or hemilaminectomy over the appropriate spinal level(s). Nishikawa et al. 32 have also described the use of partial vertebrectomy in approaching ventral cervical lesions. Intraoperative somatosensory and motor evoked potential monitoring is used. Exophytic lesions or staining/bulging of the pial surface can dictate the sagittal plane of entry into the spinal cord. Intrinsic lesions can be approached through a midline myelotomy or through the dorsal root entry zone with intraoperative real-time image guidance (ultrasonography). Such adjuncts not only facilitate lesion localization but also can be used at the conclusion of the operation to confirm complete lesion resection. 29 Once the lesion is reached, the bipolar cautery and microscissors are used to disconnect potential arterial feeders and draining veins. A cleavage plane is defined and the lesion can be removed en bloc or piecemeal using bipolar cautery with a small cottonoid placed between the malformation and hemosiderin-stained parenchyma, leaving this ring of tissue intact. Up to 94% of intramedullary CMs (mean 34% in our review) may have an associated venous malformation that should be preserved. 48 Persistent bleeding that cannot be controlled with simple irrigation should prompt a search for residual cavernoma. 7 After lesion removal, the resection cavity should be inspected and ultrasonography used to investigate for residual matter. The dura is then closed in a watertight fashion. Postoperative MR imaging is performed 3-6 months after excision, because early postoperative blood products can obscure whether the lesion has been completely excised.
Surgical Results
In early reports of surgical management for intramedullary CMs, lesions were often sampled for biopsy or partially resected. 4, 11, 41, 43 In an early review of 43 surgical case reports and small surgical series, Canavero et al. 6 reported a 74% rate of complete resection. This rate has improved to 91% in our study since the goal of surgery has become complete resection. All 3 patients with partially resected lesions in the series of Vishteh et al. 48 experienced rebleeding, underscoring the validity of this modern practice standard.
Transient worsening of sensorimotor symptoms is often seen and occurs in approximately one-third of patients. The large series of Jallo et al., 23 Vishteh et al., 48 and Matsuyama et al. 30 reported rates ranging from 24-50%. In particular, lesions approached via myelotomy through the dorsal root entry zone will often be associated with postoperative paresthesias and dysesthesias in the distribution of the nerve emerging from that entry zone. This was seen both in patients undergoing this approach in the series of Cristante and Hermann 12 and in 1 of 3 patients in the series of Park et al. 36 We found that 61% of patients improved, 27% were unchanged, and 12% were worse at the long-term followup, as compared with their preoperative status. Several studies have demonstrated that a shorter duration of preoperative symptoms 7, 23, 52 and a less compromised preoperative status 1, 6, 12, 37 are correlated with improved postoperative outcomes. Although they did not find a correlation between postoperative outcome and the timing of surgery or initial lesion grade, Labauge et al. 28 found that ventral location correlated with poorer outcomes. Patient age, sex, and lesion size have not correlated with postoperative outcome. 1, 6, 28, 52 Patients with preoperative sensory disturbances had a tendency to improve more slowly and less frequently than those with motor deficits. 12 Park et al. 36 reported a 45% rate of complete resolution of motor deficits as opposed to a 7% rate of complete resolution of preoperative sensory deficits. All patients in the series of Furuya et al. 16 experienced improvement in motor function as opposed to only 50% who had improvement in sensory deficits. Kim et al. 26 specifically evaluated resolution of preoperative pain in 23 patients, noting improvement in 78% of patients immediately after surgery but in only 48% of patients at the long-term follow-up.
Conclusions
Intramedullary spinal cord CMs can clinically and radiographically masquerade as demyelinating or neoplastic processes. Our review has demonstrated that these malformations affect middle-aged men and women in an equal proportion with at least 27% of patients harboring additional cranial lesions. Approximately one-half of patients present with progressive deficits while others present acutely or with recurrent symptomatology. We recommend complete resection for exophytic lesions. Deep lesions that do not abut the pial surface should only be resected if the patient has progressive, recurrent, or significant initial symptoms. The majority of lesions can be completely resected with only 12% of patients suffering long-term morbidity.
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